CIK 0001768446
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832273741
- Phone
- +1 866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,366,820
- in 1 filing, $1.4M under 10b5-1 plans
Net −$1,366,820. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-12 | Morisset Valerie EVP, R&D AND CSO | Sale | −50,000 | $7.07 | $354K | 294,683 |
| 2024-07-11 | Morisset Valerie EVP, R&D AND CSO | Sale | −50,000 | $7.11 | $356K | 344,683 |
| 2024-07-10 | Morisset Valerie EVP, R&D AND CSO | Sale | −50,000 | $6.83 | $342K | 394,683 |
| 2024-07-09 | Morisset Valerie EVP, R&D AND CSO | Sale | −5,931 | $6.66 | $40K | 444,683 |
| 2024-07-05 | Morisset Valerie EVP, R&D AND CSO | Sale | −12,342 | $7.06 | $87K | 450,614 |
| 2024-07-03 | Morisset Valerie EVP, R&D AND CSO | Sale | −50,000 | $6.76 | $338K | 462,956 |
| 2024-06-20 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Sale | −1,245 | $7.21 | $9K | 3,755 |
Page 2 of 2 · 27 trades